CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 03:39 (1222 d 23:28 ago) – Posting: # 18895
Views: 4,916

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

Activity
 Admin contact
21,731 posts in 4,544 threads, 1,543 registered users;
online 6 (0 registered, 6 guests [including 6 identified bots]).
Forum time: Monday 03:07 CEST (Europe/Vienna)

Law is mind without reason.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5